pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 8·1 min read
save

Democrats outline health-care priorities as they aim to retake House before November midterms

Sep 8, 2026·read at STAT ↗RegulatoryNeutral

The article notes that Democrats are sharpening their health‑care proposals as the November midterm elections approach, signaling a more detailed agenda should they regain control of the House.

House Republicans recently canceled the final two weeks of their September session, giving lawmakers a lengthy recess that stretches from Memorial Day through the election period.

During the brief period when the House was in session, a tentative outline of the Democratic health‑care plan began to take shape, highlighting the issues they would prioritize if they win back the chamber.

The piece appears in STAT’s D.C. Diagnosis newsletter, which focuses on the intersection of health policy and politics.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Health care features prominently in Democrats’ agenda”

read at STAT ↗
437 words · retrieved Sep 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTRAZENECAUltragenyx Pharmaceutical Inc.
topics
Approval2Breast CancerNeurologyOncologyRare Disease

related stories

  • Sep 14STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and moreSTAT
  • Sep 11Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra useBioPharma Dive
  • 5h agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Oct 6STAT+: AstraZeneca opens new Boston siteSTAT
  • Sep 8Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapyBioPharma Dive